Phase I and pharmacokinetic study of anhydrovinblastine every 3 weeks in patients with refractory solid tumors. (Q53657387)

From Wikidata
Jump to navigation Jump to search
scientific article published on 25 February 2003
edit
Language Label Description Also known as
English
Phase I and pharmacokinetic study of anhydrovinblastine every 3 weeks in patients with refractory solid tumors.
scientific article published on 25 February 2003

    Statements

    Phase I and pharmacokinetic study of anhydrovinblastine every 3 weeks in patients with refractory solid tumors. (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit